Discussions about the need to create a Gene and Cell therapy Society have been held in the past, mainly between hematologists involved in Gene therapy and biologists collaborating with hematologists (G. Stamatogiannopoulos, A. Athanasiadou, N. Anagnou, G. Vassilopoulos, E. Yannaki and A. Anagnostopoulos). They did not proceed to an implementation stage.
In the autumn of 2013, Achilles Anagnostopoulos took the initiative and the responsibility to form a draft statute and coordinate the procedures for the creation of the new Society. And so it was. The draft statute of the new Society included ideas from other foreign societies and the Hellenic Blood Society. In the new statute, modernizing elements have been introduced in the administration and in the election of the bodies, with the aim of maximizing participation and improving its functionality and performance. A wide and fruitful dialogue was maturely conducted online, in which the founding members participated. In the end, the synthesis of the different opinions was achieved and a functional statute emerged, a tool for progress, cooperation and promotion of the Greek scientific groups and their work. The experience of George Stamatoyannopoulos helped in key aspects of the statute and in critical points of the debate. In general there was concurrence and enthusiasm at all stages of the dialogue.
The Founding Assembly took place in Volos on June 29, 2014. The body approved the statute and elected the interim Steering Committee unanimously.